Full Text View
Tabular View
No Study Results Posted
Related Studies
Mineralocorticoid Receptor in the Treatment of Severe Depression
This study has been completed.
Study NCT00295347   Information provided by Universitätsklinikum Hamburg-Eppendorf
First Received: February 22, 2006   Last Updated: June 9, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Major Depression
Additional conditions recognized in this trial
Depression
Depressive Disorder
Depressive Disorder, Major
More general conditions related to this trial
Behavioral Symptoms
Mental Disorders
Mood Disorders
Interventions listed in this trial
Spironolactone
fludrocortisone
escitalopram
Additional drug interventions recognized in this trial
Citalopram
Mineralocorticoids
More general drug interventions related to this trial
Aldosterone Antagonists
Anti-Inflammatory Agents
Antidepressive Agents
Antidepressive Agents, Second-Generation
Cardiovascular Agents
Central Nervous System Agents
Diuretics
Hormone Antagonists
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Universitätsklinikum Hamburg-Eppendorf


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services